Oversea-Chinese Banking Corp (OCBC)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$940K Hold
2,596
– – 0.02% 265
2026
Q1
$913K Buy
+2,596
New +$925K 0.02% 228
2025
Q4
– Sell
-1,254
Closed -$354K – 324
2025
Q3
$354K Hold
1,254
– – 0.01% 286
2025
Q2
$350K Hold
1,254
– – 0.01% 280
2025
Q1
$391K Buy
1,254
+412
+49% +$122K 0.01% 304
2024
Q4
$219K Buy
+842
New +$250K 0.01% 352
2023
Q4
– Sell
-1,070
Closed -$288K – 322
2023
Q3
$288K Buy
+1,070
New +$267K 0.01% 324

Other funds holding AMGN

Oversea-Chinese Banking Corp (OCBC)'s AMGN Position: Q2 2026 in Review

Oversea-Chinese Banking Corp (OCBC) held its Amgen (AMGN) position steady in Q2 2026 at 2,596 shares worth $940K. The position accounts for 0.02% of the portfolio, ranked #265.

Oversea-Chinese Banking Corp (OCBC) first reported a position in AMGN in Q3 2023 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 2,596 shares of Amgen worth $940K as of Q2 2026.
  • Oversea-Chinese Banking Corp (OCBC) left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.02% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #265 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Amgen in Q3 2023 and has held it in 7 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.